Genmab ROI - Return on Investment 2010-2025 | GNMSF

Genmab return on investment for the quarter ending March 31, 2025 was 115.31.

  • Genmab average return on investment for 2024 was 115.31, a 0% decline from 2023.
  • Genmab average return on investment for 2023 was 115.31, a 0% decline from 2022.
  • Genmab average return on investment for 2022 was 115.31, a 0% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Genmab ROI - Return on Investment 2010-2025 | GNMSF

  • Genmab average return on investment for 2024 was 115.31, a 0% decline from 2023.
  • Genmab average return on investment for 2023 was 115.31, a 0% decline from 2022.
  • Genmab average return on investment for 2022 was 115.31, a 0% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.